Y-mAbs Therapeutics, Inc. Royalty Expense
Y-mAbs Therapeutics, Inc. reported Royalty Expense of $50.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. royalty expense for the quarter ending 2025-06-30 was $50.00K.
- Y-mAbs Therapeutics, Inc. royalty expense for the quarter ending 2024-12-31 was $200.00K.
- Y-mAbs Therapeutics, Inc. royalty expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Y-mAbs Therapeutics, Inc. royalty expense for the quarter ending 2024-06-30 was $0.00.
- Y-mAbs Therapeutics, Inc. royalty expense for fiscal 2024 was $250.00K, a 400.00% increase from fiscal 2023.
- Y-mAbs Therapeutics, Inc. royalty expense for fiscal 2023 was $50.00K.
- Y-mAbs Therapeutics, Inc. royalty expense for fiscal 2020 was $2.20M.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $50.00K 10-Q · filed 2025-08-08 | $50.00K 10-Q · filed 2025-08-08 | ||
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $200.00K derived: sum of 2 quarters · filed 2025-03-04 | $200.00K derived: sum of 3 quarters · filed 2025-08-08 | $250.00K 10-K · filed 2025-03-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2025-08-08 | $50.00K 10-Q · filed 2024-11-08 | $50.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $50.00K 10-Q · filed 2025-08-08 | $50.00K derived: sum of 3 quarters · filed 2025-08-08 | $100.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $50.00K 10-Q · filed 2025-05-13 | $50.00K derived: sum of 2 quarters · filed 2025-05-13 | $100.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $50.00K derived: sum of 2 quarters · filed 2025-03-04 | $50.00K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $50.00K 10-Q · filed 2024-11-08 | $50.00K 10-Q · filed 2024-11-08 | ||
| 2021-06-30 | $210.00K 10-Q · filed 2021-08-09 | $210.00K 10-Q · filed 2021-08-09 | ||
| 2020-12-31 | $2.20M 10-K · filed 2021-03-01 |